Reshma Autar

A highly virulent variant of HIV-1 circulating in the Netherlands

Chris Wymant, Daniela Bezemer, François Blanquart et al. · Science · 2022 · 75 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +14

HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

Colette Smit, Anders Boyd, Bart Rijnders et al. · The Lancet HIV · 2020 · 73 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Adhesion Inhibition of F1C‐Fimbriated <i>Escherichia coli</i> and <i>Pseudomonas aeruginosa</i> PAK and PAO by Multivalent Carbohydrate Ligands

Reshma Autar, Abdul Salam Khan, Matthias Schad et al. · ChemBioChem · 2003 · 64 citations · Full text

Pharmacy, Microbiology, Carbohydrate Chemistry +12

Nevirapine Plasma Concentrations and Concomitant Use of Rifampin in Patients Coinfected with HIV-1 and Tuberculosis

Reshma Autar, Ferdinand W N M Wit, Jongkol Sankote et al. · Antiviral Therapy · 2005 · 51 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily

Reshma Autar, Jintanat Ananworanich, W. Apateerapong et al. · Journal of Antimicrobial Chemotherapy · 2004 · 41 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17